Synopsys Fell 11% This Year. Wall Street Expects It to Gain 50% in the Next 12 Months

Synopsys (NASDAQ:SNPS | SNPS Price Prediction) currently trades at $416.31, while Wall Street’s average 12-month price target sits at $544.97, an implied upside of roughly 31% from here. Street-high targets stretch that gap toward 50%, which is the version of the story most bullish analysts are telling.

Synopsys is one half of the electronic design automation duopoly that every advanced chip in the world runs through. Following its roughly $35 billion acquisition of Ansys, closed in the third quarter of fiscal 2025, the company now pitches itself as a silicon-to-systems engineering platform spanning chip design, multiphysics simulation, and semiconductor IP.

Wall Street has been paying attention because AI-driven chip complexity is exactly the kind of secular tailwind that lifts EDA license values. Yet the stock is down 11.37% year to date while the S&P 500 is up 13.38%. That disconnect is the setup.

An Ansys Hangover, a Debt Load, and a Design IP Cloud

The selloff began with digestion of the Ansys deal. Long-term debt spiked to $13.46 billion at fiscal 2025 close and still sits near $10 billion after aggressive H1 paydowns, a heavy balance sheet for a company that historically ran net cash. GAAP margins are also being compressed by roughly $404 million per quarter in intangibles amortization, and planned Q4 restructuring charges will add more noise to reported profits.

Sentiment took a second hit from the Design IP segment. A Morgan Stanley downgrade earlier in the fiscal year flagged growth deceleration risk, and shareholder lawsuits alleging misrepresentation of Design IP’s financial stability emerged around the fiscal 2025 filing. Layer in export-control and Entity List overhang tied to China exposure, and the market decided to trim the multiple even though revenue growth stayed robust.

The pain has been company-specific rather than sector-wide. Over the past week alone, SNPS fell 10.45%, well beyond typical volatility for a name of this size.

Why the Sell-Side Is Sticking With the Bull Case

Analysts are pointing at the earnings report. Q3 fiscal 2026 revenue hit $2.48 billion, up 42.4% year over year, beating consensus, with non-GAAP EPS of $3.91 topping the $3.67 estimate. Management raised full-year revenue guidance to $9.69 to $9.74 billion and non-GAAP EPS to $15.04 to $15.10, and guided EDA growth to accelerate to double digits in Q4.

The bull thesis rests on three pillars. AI is forcing customers into 2nm and 1.4nm nodes, multi-die chiplets, and gate-all-around architectures, all of which command higher license values. Ansys synergies are ahead of schedule, with management reaffirming the $400 million year-four synergy target. And Design IP has already returned to growth at $474 million, up roughly 11% year over year, undercutting the litigation narrative.

Coverage skews decisively positive. Of 25 analysts tracked, 3 rate Synopsys Strong Buy, 16 Buy, 5 Hold, 0 Sell, and 1 Strong Sell. Recent revisions have leaned higher, with 17 upward EPS revisions in the past 30 days for fiscal 2027 and zero downward. Berenberg’s Nay Soe Naing sits at the top end with a Buy rating and a $633 price target, citing the non-discretionary nature of EDA software and the hyperscaler in-house silicon boom.

Cadence Held Up, Autodesk Did Not, Keysight Ran

The EDA and engineering-software peer group did not sell off together. Synopsys fell largely alone, while its closest rival held firmer and adjacent names went in opposite directions.

Cadence Design Systems (NASDAQ:CDNS) is the direct EDA peer and is down only 2.46% year to date at $304.88 against a $403.12 average target, implying roughly 32% upside. Coverage is nearly unanimous with 5 Strong Buy, 17 Buy, and 3 Hold ratings, and Cadence carries no Ansys-sized debt burden.

Autodesk (NASDAQ:ADSK) is the adjacent engineering-software comp and has fared worse than SNPS, down 19.76% year to date at $237.52. The average target of $315.37 pencils to about 33% upside, and the ratings mix runs 6 Strong Buy, 24 Buy, and 6 Hold, with revisions trending up post-Q2.

Keysight Technologies (NYSE:KEYS) rounds out the group as a test-and-measurement adjacency and is the odd one out, up 58.78% year to date on AI data center testing demand, leaving less obvious upside from here. Across the three, Autodesk edges Synopsys on implied upside, but SNPS offers the cleanest exposure to the AI silicon buildout.

What the Data Actually Says

Synopsys currently trades at $416.31 versus the consensus target of $544.97, an implied upside of roughly 31%. The 25 analysts covering the name tilt heavily positive, with 19 Buy-equivalent ratings against only 5 Holds and one lone Strong Sell. Shares carry a forward P/E of 24, which is not stretched given raised guidance.

The near-term picture is ugly. SNPS is down 29.69% over the past year versus a 20.11% gain for the S&P 500, and it has underperformed the index by nearly 25 percentage points year to date. Longer-term holders are still well ahead, with the stock up 597.69% over ten years.

Buying the Duopoly, With Eyes Open

The bull case holds together if the Ansys integration keeps tracking ahead of plan and Design IP holds its recovery. The path back to the target is straightforward: double-digit EDA growth into fiscal 2027, continued debt paydown, and evidence that Multiphysics Fusion is winning genuine incremental spend rather than cannibalizing existing tools.

The thesis weakens if China export restrictions tighten meaningfully, or if the shareholder litigation surfaces a real earnings-quality issue in Design IP. A debt load near $10 billion also limits flexibility if AI design spend pauses. On balance, the risk/reward tilts positive. This looks like a dislocation, and investors should size the position for the volatility that has clearly returned to the name.

Contact [email protected] for any questions or corrections.